FDA Inspection 1018163 — Precision Occular Network
The FDA completed an inspection of Precision Occular Network on May 12, 2017 in Huntsville, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 12, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Huntsville, AL (United States)